Form 4 Filing for BIOLIFE SOLUTIONS INC

2026-10-08SEC Filing 4 (0001193125-26-418316)

Timothy L. Moore, a director at BIOLIFE SOLUTIONS INC, reported a disposition of 44,943 shares of common stock on October 6, 2026. This disposition occurred in connection with the merger of Bravo Merger Sub I, Inc. with and into BioLife Solutions, Inc. Each share of common stock was converted into $11.25 in cash and 0.1442 shares of Repligen common stock. Following the transaction, Mr. Moore has no directly or indirectly owned shares. The filing is a Form 4, indicating a transaction by an insider.